JAY M MOYES
CIK 1191062 · Chief Financial Officer · last filed 2026-02-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$579.6K
Companies
10
Total Filings
76
Lifetime Open-Market Net
-$7.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SINT | Director | 4,000 | $2.12 | $8.5K | $13.7K | 2 | 2026-02-25 |
| BCDA | Director | — | $0.88 | — | $0 | 5 | 2025-12-10 |
| PBYI | Director | 53,322 | $7.33 | $390.9K | -$760.8K | 21 | 2025-06-17 |
| BioCardia, Inc. (BCDAW) Delisted | Director | 54,267 | $0.01 | $331 | $0 | 10 | 2023-10-19 |
| SERA | Chief Financial Officer | 35,630 | $1.87 | $66.6K | $0 | 3 | 2023-03-07 |
| ACHV | Director | — | $5.52 | — | $0 | 6 | 2022-06-01 |
| ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Director | — | — | — | $0 | 1 | 2017-08-03 |
| Sintx Technologies, Inc. (AMDA) Delisted | Chief Financial Officer | 66,562 | — | — | $0 | 1 | 2014-02-21 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Director | 26,500 | — | — | $0 | 8 | 2014-02-07 |
| MYGN | Chief Financial Officer | 26,256 | $4.33 | $113.7K | -$6.29M | 18 | 2007-10-16 |
Recent Filings · Page 5 of 8
76 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-06-14 | PBYI | Grant (A) | — | $0 | EDGAR |
| 2017-01-18 | BCDA | Grant (A) | — | $0 | EDGAR |
| 2016-11-16 | PBYI | Grant (A) | — | $0 | EDGAR |
| 2015-12-17 | PBYI | Grant (A) | — | $0 | EDGAR |
| 2015-08-27 | PBYI | Grant (A) | — | $0 | EDGAR |
| 2014-12-16 | PBYI | Grant (A) | — | $0 | EDGAR |
| 2014-02-21 | Sintx Technologies, Inc. (AMDA) Delisted | Conv (C) | +7,784 | $0 | EDGAR |
| 2014-02-07 | OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Grant (A) | +5,000 | $74.7K | EDGAR |
| 2013-12-20 | PBYI | Grant (A) | — | $0 | EDGAR |
| 2013-02-13 | OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Grant (A) | +5,000 | $38.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.